The "U.S. In-Vitro Diagnostics Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.
The U.S. In-Vitro Diagnostics Market was valued at USD 40.79 billion in 2023, and is projected to reach USD 44.95 billion by 2029, showcasing a CAGR of 1.63%.
The U.S. in-vitro diagnostics (IVDs) market report contains exclusive data on 83 vendors. The competition among market players in the IVD market is significantly high for products, solutions, reagents, consumables, and services in terms of pricing, product, and associated brand image, services, and associated quality, a new product launched and developed, customer services, and financing terms.
The leading market players in the US IVD market are F Hoffmann-La Roche, Abbott, Thermo Fisher Scientific, Diasorin, Biomerieux, Danaher, Bio-Rad, and Siemens Healthineers, competing with rapidly emerging market players. Vendors in the market are increasing their market share through inorganic growth strategies.
Growing Importance of IVD In Healthcare
The technological innovation and its application in healthcare are leading to the practical implementation of new treatment methods. The expectations for personalized medicine are growing, wherein medication and treatment are tailored to each patient's unique characteristics and medical condition. Testing is likely to play an increasingly important role in healthcare, as the realization of personalized medicine will require testing to confirm individual characteristics. For instance, cancer genomic medicine, which has begun earnestly, requires analysis of genetic information within cancer cells through genetic testing. Sysmex is working to achieve this type of cancer genomic medicine and to make liquid biopsy a reality.
Increasing Adoption Of Automation in Laboratories
Integrating automation into the IVD manufacturing process has many benefits for IVD device designers and manufacturers. Automation allows for the inclusion of software-based calculation, calibration, and documentation, improving test efficiency, calibration schedules, regulatory compliance, and instrument/equipment traceability. These benefits reduce labor, lower error (standardization) risk, and fewer calibration tests. Furthermore, automated volumetric measurements simplify production fabrication processes by giving manufacturers better control over manufacturing equipment and steps in the production line.
U.S. IN-VITRO DIAGNOSTICS MARKET HIGHLIGHTS
KEY QUESTIONS ANSWERED
Key Attributes:
Report Attribute | Details |
No. of Pages | 115 |
Forecast Period | 2023 - 2029 |
Estimated Market Value (USD) in 2023 | $40.79 Billion |
Forecasted Market Value (USD) by 2029 | $44.95 Billion |
Compound Annual Growth Rate | 1.6% |
Regions Covered | United States |
Vendors List
Key Vendors
Other Prominent Vendors
SEGMENTATION & FORECAST
Products & Services
Application
End-Users
For more information about this report visit https://www.researchandmarkets.com/r/kd61ij
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
These press releases may also interest you
|